Ascendia Pharmaceutical Solutions

Private

New JerseyHealthcare & Life Scienceshttps://ascendiacdmo.com/

Last Round

Growth Equity

Apr 8, 2021

Company Overview

Ascendia Pharmaceutical Solutions is a pharmaceutical company that provides contract development and manufacturing (CDMO) services, including pre-formulation, formulation development, and cGMP manufacturing for a variety of dosage forms.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Advanced Materials, Pharma Supply Chain

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

CDMOformulation developmentcontract development and manufacturing organizationdrug solubilityspecialty CDMOcGMP manufacturingbioavailability enhancementlipid nanoparticle technologyLNPspharma outsourcingdrug deliverysterile manufacturingclinical trial material supplyCTM supplypharmaceutical nanotechnologyamorphous solid dispersionanalytical services

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ascendia Pharmaceutical Solutions Comps

Public and private peers based on sector, stage, and business model.

Ascendia Pharmaceutical Solutions comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Ascendia Pharmaceutical Solutions Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Growth Equity	Apr 8, 2021

View all Funding Rounds

Ascendia Pharmaceutical Solutions Investors

Notable investors and investment history

Ascendia Pharmaceutical Solutions investors
Investor	Rounds
Signet Healthcare Partners	Growth Equity

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Apr 8, 2021
Raised Growth Equity round led by Signet Healthcare Partners.

View all signals

Ascendia Pharmaceutical Solutions Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Ascendia Pharmaceutical Solutions Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Ascendia Pharmaceutical Solutions's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew Jersey

Year Founded2012

Last FundingApr 8, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.